Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$8.12 - $10.63 $186,654 - $244,351
22,987 New
22,987 $239,000
Q2 2023

Aug 15, 2023

BUY
$7.2 - $9.47 $142,128 - $186,937
19,740 Added 61.99%
51,585 $388,000
Q1 2023

May 12, 2023

BUY
$8.36 - $11.37 $266,224 - $362,077
31,845 New
31,845 $281,000
Q3 2022

Nov 14, 2022

SELL
$6.86 - $11.95 $377,203 - $657,082
-54,986 Reduced 78.91%
14,699 $119,000
Q2 2022

Aug 12, 2022

SELL
$7.38 - $10.4 $159,858 - $225,274
-21,661 Reduced 23.71%
69,685 $524,000
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $1.33 Million - $1.7 Million
-180,906 Reduced 66.45%
91,346 $858,000
Q4 2021

Feb 11, 2022

BUY
$7.9 - $10.19 $2.15 Million - $2.77 Million
272,252 New
272,252 $2.18 Million
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $560,923 - $681,408
-66,936 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$9.9 - $11.56 $662,666 - $773,780
66,936 New
66,936 $663,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Blueshift Asset Management, LLC Portfolio

Follow Blueshift Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blueshift Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blueshift Asset Management, LLC with notifications on news.